Cytochrome 450 1B1 (CYP1B1) polymorphisms associated with response to docetaxel in Castration-Resistant Prostate Cancer (CRPC) patients

Cytochrome 450 1B1 (CYP1B1) polymorphisms associated with response to docetaxel in Castration-Resistant Prostate Cancer (CRPC) patients

<p>Abstract</p> <p>Background</p> <p>The selection of patients according to key genetic characteristics may help to tailor chemotherapy and optimize the treatment in Castration-Resistant Prostate Cancer (CRPC) patients. Functional polymorphisms within the <it>cyto...

Full description

Bibliographic Details
Main Authors:	Price Douglas K, Orlandini Cinzia, Crea Francesco, Sissung Tristan M, Chioni Aldo, Giovannetti Elisa, Pastina Ilaria, Cianci Claudia, Figg William D, Ricci Sergio, Danesi Romano
Format:	Article
Language:	English
Published:	BMC 2010-09-01
Series:	BMC Cancer
Online Access:	http://www.biomedcentral.com/1471-2407/10/511

Similar Items

Pembrolizumab (pembro) for docetaxel-pretreated metastatic Castration-Resistant Prostate Cancer (mCRPC): Update on KEYNOTE-199, cohorts 1-3
by: J.M. Piulats, et al.
Published: (2020-07-01)

Cytochrome P450 1B1 and primary congenital glaucoma
by: Yun Zhao, et al.
Published: (2015-01-01)

Selective inhibitors of the cytochrome p450 enzyme CYP1B1
by: Tan, Hoon Leong
Published: (2006)

Risk factors for metastatic castration-resistant prostate cancer (CRPC) predict long-term treatment with docetaxel.
by: Takashi Kawahara, et al.
Published: (2012-01-01)

Comparative Computational Studies on Selective CytochromeP450 1B1 Inhibitors
by: Mohd Usman Mohd Siddique, et al.
Published: (2020-09-01)

Expression of cytochrome P450 1B1 in preneoplastic conditions of the colon and cervix
by: Hoang, Thuong
Published: (2003)

Expression and characterisation of modified human cytochrome P450 (CYP1B1)
by: Wilgoss, Amanda Louise
Published: (2005)

Role of cytochrome P450 monooxygenase in the bioactivation of aflatoxin B1
by: Sureeporn Nualkaew, et al.
Published: (2017)

Correlation and individual variation of aryl hydrocarbon receptor, Ah-receptor nuclear translocator, cytochrome P450 1A1 and cytochrome P450 1B1 in peripheral lymphocytes
by: 張慈華
Published: (2002)

Could ketoconazole predict the response of abiraterone in patients with metastatic castration-resistant prostate cancer (crpc) pre-treated with docetaxel
by: Bo-Han Chen, et al.
Published: (2015-06-01)

Pharmacophore Modeling and in Silico/in Vitro Screening for Human Cytochrome P450 11B1 and Cytochrome P450 11B2 Inhibitors
by: Muhammad Akram, et al.
Published: (2017-12-01)

A novel methodology for enhanced and consistent heterologous expression of unmodified human cytochrome P450 1B1 (CYP1B1).
by: Muneeb A Faiq, et al.
Published: (2014-01-01)

Validation of cytochrome P450 1B1 as a target for the enzyme prodrug therapy of cancer
by: Greer, Mhairi Louise
Published: (2005)

The molecular pathology of Castrate Resistant Prostate Cancer (CRPC)
by: Paul Mainwaring
Published: (2015-12-01)

ROLE OF HEPATIC CYTOCHROME P450 2B1/2 IN PROPOFOL METABOLISM
by: 林怡伶
Published: (2004)

Expression of Bioactive Zebrafish Cytochrome P450 1B1 Recombinant Protein in Baculovirus Expression System
by: Chun-Kai Huang, et al.
Published: (2010)

The induction of cytochrome P450 1A1 by metyrapone
by: Harvey, Joanna Louise
Published: (1998)

Hormonal Therapeutics Enzalutamide and Abiraterone Acetate in the Treatment of Metastatic Castration-Resistant Prostate Cancer (mCRPC) Post-docetaxel—an Indirect Comparison
by: Pui S. Tan, et al.
Published: (2014-03-01)

Hormonal Therapeutics Enzalutamide and Abiraterone Acetate in the Treatment of Metastatic Castration-Resistant Prostate Cancer (mCRPC) Post-docetaxel—an Indirect Comparison
by: Pui S. Tan, et al.
Published: (2014-01-01)

Value of Early Circulating Tumor Cells Dynamics to Estimate Docetaxel Benefit in Metastatic Castration-Resistant Prostate Cancer (mCRPC) Patients
by: Rebeca Lozano, et al.
Published: (2021-05-01)

Cytochrome P450 isoforms 1A1, 1B1 AND 2W1 as targets for therapeutic intervention in head and neck cancer
by: Daniela Presa, et al.
Published: (2021-09-01)

Absence of Cytochrome P450-1b1 Increases Susceptibility of Pressure-Induced Axonopathy in the Murine Retinal Projection
by: Naseem Amirmokhtari, et al.
Published: (2021-03-01)

Cytochrome P450 1B1 (CYP1B1) is over-expressed in human colon adeno-carcinomas relative to normal colon: Implications for drug development.
by: Gibson, Paul, et al.
Published: (2009)

An electron transfer competent structural ensemble of membrane-bound cytochrome P450 1A1 and cytochrome P450 oxidoreductase
by: Goutam Mukherjee, et al.
Published: (2021-01-01)

EROD and MROD as Markers of Cytochrome P450 1A Activities in Hepatic Microsomes from Entire and Castrated Male Pigs
by: Vladimir Zlabek, et al.
Published: (2009-03-01)

Mechanistic Scrutiny Identifies a Kinetic Role for Cytochrome b5 Regulation of Human Cytochrome P450c17 (CYP17A1, P450 17A1).
by: Alexandr N Simonov, et al.
Published: (2015-01-01)

Studies on cytochrome P450 4X1
by: Al-Anizy, Mohammed
Published: (2005)

Expression and activities of hepatic cytochrome P450 (CYP1A, CYP2A and CYP2E1) in entire and castrated male pigs
by: C. Brunius, et al.
Published: (2012-01-01)

Bioactivation and Regioselectivity of Pig Cytochrome P450 3A29 towards Aflatoxin B1
by: Jun Wu, et al.
Published: (2016-09-01)

The effect of Prostaglandin E2 on Phenobarbital induced cytochrome P450 2B1 expression
by: Chih Chung Chen, et al.
Published: (2003)

Curcumin Prevents Aflatoxin B1 Hepatoxicity by Inhibition of Cytochrome P450 Isozymes in Chick Liver
by: Ni-Ya Zhang, et al.
Published: (2016-11-01)

KEYNOTE-365 cohort B updated results: Pembrolizumab (pembro) plus docetaxel and prednisone in abiraterone (abi) or enzalutamide (enza) pre-treated patients with metastatic castration-resistant prostate cancer (mCRPC)
by: G. Gravis, et al.
Published: (2020-07-01)

Aryl Hydrocarbon Receptor and Cytochrome P450 1B1 Expression in Human Normal Lung as well as Lung Tumor Tissues
by: Meng-hsiang Wu, et al.
Published: (2001)

Modulation of porcine cytochrome P450 enzyme activities by surgical castration and immunocastration
by: G. Zamaratskaia, et al.
Published: (2009-01-01)

Exploring the Potential of Cytochrome P450 CYP109B1 Catalyzed Regio—and Stereoselective Steroid Hydroxylation
by: Xiaodong Zhang, et al.
Published: (2021-02-01)

Studies of the structure of cytochrome P450 4A1
by: Fan, Ming Qi
Published: (2002)

Current and Emerging Therapies for Metastatic Castration-Resistant Prostate Cancer (mCRPC)
by: Iván Henríquez, et al.
Published: (2021-09-01)

Cytochrome P450 CYP1B1 interacts with 8-methoxypsoralen (8-MOP) and influences psoralen-ultraviolet A (PUVA) sensitivity.
by: Yusuf Y Deeni, et al.
Published: (2013-01-01)

Multiple CH/π Interactions Maintain the Binding of Aflatoxin B1 in the Active Cavity of Human Cytochrome P450 1A2
by: Jun Wu, et al.
Published: (2019-03-01)

Investigation of cytochrome p450 isoforms 1A1, 1B1 and 2W1 as targets for therapeutic intervention in head and neck cancer. Probing CYP1A1, 1B1 and 2W1 activity with duocarmycin bioprecursors
by: Presa, Daniela
Published: (2020)

Cannot write session to /tmp/vufind_sessions/sess_de68dl89jdv509v0o01d8bddm1